A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits-Reference-Cited by-同舟云学术

A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits

Published:2004-10 Issue:2 Volume:176 Page:255-263
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Hayashi Toshio,Rani P Juliet Arockia,Fukatsu Akiko,Matsui-Hirai Hisako,Osawa Masako,Miyazaki Asaka,Tsunekawa Taku,Kano-Hayashi Hatsuyo,Iguchi Akihisa,Sumi Daigo,Ignarro Louis J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Regulation of the mevalonate pathway;Goldstein;Nature,1990

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N. Eng. J. Med,1995

3. Scandinavian Simvastatin Study Group. Randomized trial of cholesterol lowering therapy in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.

4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS;Downs;JAMA,1998

5. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349–57.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing efficacy and safety of plasmapheresis versus atorvastatin in pathological progression of atherosclerosis in a rodent model;Tropical Journal of Pharmaceutical Research;2021-12-13

2. A comprehensive review on the lipid and pleiotropic effects of pitavastatin;Progress in Lipid Research;2021-11

3. Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development;Applied Sciences;2020-12-04

4. Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression;Journal of Controlled Release;2019-08

5. Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study);Vascular Health and Risk Management;2018-09